CrisprBits Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.02M

  • Investors
  • 5

CrisprBits General Information

Description

Operator of a health tech firm intended to address critical healthcare needs. The company leverages gene-editing technology to develop innovative diagnostic tools, advanced cell therapies, and disease models, enabling healthcare professionals to improve patient outcomes, accelerate drug discovery, and advance medical research.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Plot Number 3, F-301, III Floor Ashish Complex LSC
  • New Rajdhani Enclave, Vikas Marg
  • Delhi, 110092
  • India
+91 081054
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Plot Number 3, F-301, III Floor Ashish Complex LSC
  • New Rajdhani Enclave, Vikas Marg
  • Delhi, 110092
  • India
+91 081054

CrisprBits Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CrisprBits Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 25-Nov-2025 $3.02M Completed Generating Revenue
4. Seed Round 13-Feb-2023 Completed Generating Revenue
3. Seed Round 06-Jun-2022 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view CrisprBits’s complete valuation and funding history, request access »

CrisprBits Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
Ordinary Shares
Ordinary Shares 28,736 $0.112718 $1.38 $1.38 1x $1.38 7.3%
To view CrisprBits’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CrisprBits Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a health tech firm intended to address critical healthcare needs. The company leverages gene-editing technol
Drug Discovery
Delhi, India
30 As of 2025

Mumbai, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CrisprBits Competitors (1)

One of CrisprBits’s competitors is 23IKIGAI, a Venture Capital-Backed company based in Mumbai, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
23IKIGAI Venture Capital-Backed Mumbai, India
You’re viewing 1 of 1 competitors. Get the full list »

CrisprBits Patents

CrisprBits Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026099887-A1 "guide rna and method of detection of sickle cell disease" Pending 05-Nov-2024
WO-2024134572-A1 Sequences and methods for crispr-based detection of omicron 5 variant of sars-cov-2 Inactive 21-Dec-2022
EP-4460581-A1 Assay device, method for determining genetic predisposition to severe forms of sars-cov2 infection Pending 30-Sep-2021
US-20240401111-A1 Assay device, method for determining genetic predisposition to severe forms of sars-cov2 infection Pending 30-Sep-2021
WO-2023053089-A1 Assay device, method for determining genetic predisposition to severe forms of sars-cov2 infection Inactive 30-Sep-2021 C12Q1/6818
To view CrisprBits’s complete patent history, request access »

CrisprBits Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CrisprBits Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Centre for Cellular And Molecular Platforms Accelerator/Incubator Minority
Spectrum Impact Family Office Minority
Vj Technologies Corporation Minority
India Pistons Corporation Minority
BITS BioCyTiH Foundation Accelerator/Incubator Minority
To view CrisprBits’s complete investors history, request access »

CrisprBits FAQs

  • When was CrisprBits founded?

    CrisprBits was founded in 2020.

  • Where is CrisprBits headquartered?

    CrisprBits is headquartered in Delhi, India.

  • What is the size of CrisprBits?

    CrisprBits has 30 total employees.

  • What industry is CrisprBits in?

    CrisprBits’s primary industry is Drug Discovery.

  • Is CrisprBits a private or public company?

    CrisprBits is a Private company.

  • What is the current valuation of CrisprBits?

    The current valuation of CrisprBits is .

  • What is CrisprBits’s current revenue?

    The current revenue for CrisprBits is .

  • How much funding has CrisprBits raised over time?

    CrisprBits has raised $3.53M.

  • Who are CrisprBits’s investors?

    Centre for Cellular And Molecular Platforms, Spectrum Impact, Vj Technologies, India Pistons, and BITS BioCyTiH Foundation have invested in CrisprBits.

  • Who are CrisprBits’s competitors?

    23IKIGAI is a competitor of CrisprBits.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process